Abstract submission for the 2018 meeting is closed. Abstracts are now under review. Program decisions will be communicated to the submitters in early August.

  • The abstract deadline is June 4, 2018, 11:59pm CST
  • Abstracts are limited to 300 words; figures and tables are not allowed
  • Abstract titles should use sentence case (i.e., only the first letter of the title should be capitalized)
  • The body of the abstract should be in a single paragraph. If subheaders are used, they should be within that single paragraph in all-caps, not bolded (e.g., METHODS:)
  • Abstracts should be data-driven and must include this information in the body of the abstract
  • The embargo for abstracts published in the 2018 abstract supplement to SNO official journal Neuro-Oncology will lift at 7:00 AM (EST) on Monday, November 5, 2018. These abstracts will be made available at: https://academic.oup.com/neuro-oncology
  • New this year, SNO will record all slide presentations (with accompanying audio) made during the meeting. Select presentations will be featured on the SNO Education Site and will be made available for online viewing. Poster files will be captured and available on the mobile meeting app. Presenters will be given full credit for their presentations. For the purpose of Neuro-Oncology, Neuro-Oncology Practice, and other scholarly journals, presentation in either of these  forums is not considered "prior publication".
  • For information and special guidelines on Late-Breaking Abstractsclick here.


Abstracts will be accepted in the following categories (* denotes new categories added for 2018):


  • Angiogenesis and Invasion
  • Cell Biology and Metabolism
  • Cell Signaling and Signaling Pathways
  • Drug Discovery
  • Drug Resistance
  • Experimental Therapeutics
  • Genetics and Epigenetics
  • Immunology    
  • Pediatric Tumors
  • Radiation Biology and DNA Repair*
  • Stem Cells
  • Tumor Microenvironment
  • Tumor Models
  • Computational Omics*
  • Late Breaking



  • Adult Clinical Trials-Immunologic
  • Adult Clinical Trials-non-Immunologic    
  • CNS Metastasis
  • Epidemiology
  • Meningioma
  • Health Outcome Measures
  • Innovations in Patient Care*
  • Molecular Pathology and Classification-Adult and Pediatric
  • Neuro-Cognitive Outcomes
  • Neuroimaging
  • Neurological Complications of Cancer and Cancer Therapy
  • Pediatric Clinical Trials
  • Quality of Life and Palliative Care
  • Radiation Therapy
  • Rare Tumors
  • Surgical Therapy
  • Randomized Brain Tumor Trials in Development*